A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

Recently, Capricor announced that it had initiated its rolling Biologics License Application (BLA) submission process with the U.S. FDA seeking full approval of deramiocel to treat all patients ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

If the European Commission decides to grant sales of the medicine, it will be the first Alzheimer's medicine available in the ...

Reversing an earlier decision, European regulators recommended that an Alzheimer’s therapy from Eisai and Biogen should be ...

The European Union health agency on Monday warned that Europe was set to miss goals on reducing the use of antibiotics, ...

MEDIA RELEASEAfqlir® (aflibercept) approved to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD)One ...

The EMA sided against the drug this summer. But an appeal from Eisai appears to have worked, teeing Leqembi up for authorization in a major market.

Shares in European vaccine makers tumbled after President-elect Donald Trump picked vaccine sceptic Robert F. Kennedy Jr. to ...

The Netherlands previously conducted a successful lobby for the European Medicines Agency (EMA). The agency moved from London to Amsterdam a few years ago due to Britain’s departure from the European ...

New Delhi: Drugs to treat lifestyle diseases such as hypertension and type 2 diabetes were among the top-selling medicines at the ... Bureau of India (PMBI), the agency implementing the PMBJP.

President-elect Trump is tapping Brendan Carr of the Federal Communications Commission (FCC) to chair the agency. Trump said he first nominated Carr to the FCC in 2017 and he was confirmed ...